You are here: Home » Companies » News
Business Standard

Cipla recalls 4,800 bottles of anti-HIV tablets from American market

As per the latest Enforcement Report by the USFDA, the reason for the recall of the bottles is 'failed dissolution specifications'

Press Trust of India  |  New Delhi 

v
Representative Image

Drug major is recalling 4,800 bottles of Nevirapine extended release tablets used for the treatment of human immunodeficiency virus (HIV) from the American market, according to a report by the US regulator.

As per the latest Enforcement Report by the Food and Drug Administration (USFDA), the reason for the recall of the bottles is 'failed dissolution specifications'.

Nevirapine extended release tablets, 400 mg in the 30-count bottle have been manufactured by at its facility for USA Inc, it added.

The US regulator has not yet classified the voluntary recall by the company, the report said.

First Published: Sun, December 30 2018. 11:40 IST
RECOMMENDED FOR YOU